CTLA4 Polymorphisms and De Novo Malignancy Risk after Renal Transplantation in Chinese Recipients

Table 3

The flounce on incidence of malignancy for rs231775 AA in gene-environment interaction and gene-gene interaction.

Variables	Tumor ()	Nontumor ()
Mean age ± SD	40.72 ± 9.47	40.18 ± 10.10	0.712
Sex
Male/female	35/18	253/158	0.306
Primary diseases			0.021
Dialysis time (≥3 years)	23	193	0.078
Number of HLA-mismatch	2.57 ± 1.029	2.47 ± 0.806	0.006
Antibody induction therapy	17	140	0.364
Rejection
AR/non-AR	11/42	53/358	0.331